FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Promethazine Hydrochloride Injection, Solution
Status: Discontinuation
»Therapeutic Categories: Anesthesia; Gastroenterology; Pulmonary/Allergy

Expand all

Teva Pharmaceuticals (New 12/19/2019)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
25 mg/1 mL, 1 vial Single-Dose (NDC 0703-2191-01) 12/19/2019 Teva made a business decision to discontinue this product.
50 mg/1 mL Injection, 1 Vial Single-Dose (NDC 0703-2201-01) 12/19/2019 Teva made a business decision to discontinue this product.
25 mg/1 mL, 25 in 1 tray (NDC 0703-2191-04) 12/19/2019 Teva made a business decision to discontinue this product.
50 mg/1 mL, 25 in 1 tray (NDC 0703-2201-04) 12/19/2019 Teva made a business decision to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English